Mirum Pharmaceuticals Inc
NASDAQ:MIRM

Watchlist Manager
Mirum Pharmaceuticals Inc Logo
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
Watchlist
Price: 50.73 USD 0.91%
Market Cap: 2.5B USD

Intrinsic Value

The intrinsic value of one MIRM stock under the Base Case scenario is 44.92 USD. Compared to the current market price of 50.73 USD, Mirum Pharmaceuticals Inc is Overvalued by 11%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MIRM Intrinsic Value
44.92 USD
Overvaluation 11%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Mirum Pharmaceuticals Inc

Valuation History Unavailable

Historical valuation for MIRM cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare MIRM to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MIRM?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Mirum Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Mirum Pharmaceuticals Inc

Current Assets 410.8m
Cash & Short-Term Investments 277.7m
Receivables 95.9m
Other Current Assets 37.3m
Non-Current Assets 279.4m
Long-Term Investments 20.9m
PP&E 8.8m
Intangibles 243.8m
Other Non-Current Assets 5.9m
Efficiency

Free Cash Flow Analysis
Mirum Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Mirum Pharmaceuticals Inc

Revenue
379.3m USD
Cost of Revenue
-86.8m USD
Gross Profit
292.4m USD
Operating Expenses
-368.7m USD
Operating Income
-76.3m USD
Other Expenses
-1m USD
Net Income
-77.3m USD
Fundamental Scores

MIRM Profitability Score
Profitability Due Diligence

Mirum Pharmaceuticals Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

36/100
Profitability
Score

Mirum Pharmaceuticals Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

MIRM Solvency Score
Solvency Due Diligence

Mirum Pharmaceuticals Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Positive Net Debt
Average D/E
42/100
Solvency
Score

Mirum Pharmaceuticals Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MIRM Price Targets Summary
Mirum Pharmaceuticals Inc

Wall Street analysts forecast MIRM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MIRM is 71.74 USD with a low forecast of 55.55 USD and a high forecast of 82.95 USD.

Lowest
Price Target
55.55 USD
10% Upside
Average
Price Target
71.74 USD
41% Upside
Highest
Price Target
82.95 USD
64% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Mirum Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MIRM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

MIRM Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one MIRM stock?

The intrinsic value of one MIRM stock under the Base Case scenario is 44.92 USD.

Is MIRM stock undervalued or overvalued?

Compared to the current market price of 50.73 USD, Mirum Pharmaceuticals Inc is Overvalued by 11%.

Back to Top